Cogent Biosciences, Inc. COGT
31.65 USD +2.07 (+6.98%)
At closeNov 6, 2026, 4:00 PM EST
31.65 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
28.97 Day range 31.69
14.72 52-week range 42.84
- YTD
- -10.91%
- 1 year
- +114.98%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -333.36M | -275.94M | -208.13M | -147.84M | -75.55M | |
| -328.94M | -255.86M | -192.41M | -140.24M | -72.27M | |
| -2.16 | -1.94 | -1.94 | -1.73 | -1.87 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 312.43M | 98.17M | 53.23M | 141.14M | 220.94M | |
| 937.61M | 327.90M | 313.44M | 300.81M | 232.09M | |
| 301.24M | 71.61M | 55.63M | 45.08M | 17.91M | |
| 238.80M | 17.47M | 18.85M | 19.65M | 3.15M | |
| 636.37M | 256.29M | 257.80M | 255.74M | 214.18M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -264.44M | -207.79M | -153.62M | -118.64M | -58.76M | |
| -399.53M | 38.28M | -97.82M | -124.72M | -1.72M | |
| 878.23M | 214.45M | 163.54M | 163.56M | 37.98M | |
| -1.55M | -573.00K | -2.80M | -6.86M | -1.72M | |
| 214.26M | 44.94M | -87.91M | -79.80M | -22.51M |